These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26525786)

  • 21. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
    Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
    J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyruvate secretion by oral streptococci modulates hydrogen peroxide dependent antagonism.
    Redanz S; Treerat P; Mu R; Redanz U; Zou Z; Koley D; Merritt J; Kreth J
    ISME J; 2020 May; 14(5):1074-1088. PubMed ID: 31988475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Host Cell Oxidative Stress Promotes Intracellular Fluoroquinolone Persisters of Streptococcus pneumoniae.
    Hernandez-Morfa M; Reinoso-Vizcaíno NM; Olivero NB; Zappia VE; Cortes PR; Jaime A; Echenique J
    Microbiol Spectr; 2022 Dec; 10(6):e0436422. PubMed ID: 36445159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
    Weigel LM; Anderson GJ; Facklam RR; Tenover FC
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3517-23. PubMed ID: 11709333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microarray analysis of macrophage response to infection with Streptococcus oralis reveals the immunosuppressive effect of hydrogen peroxide.
    Matsushima H; Kumagai Y; Vandenbon A; Kataoka H; Kadena M; Fukamachi H; Arimoto T; Morisaki H; Fujiwara N; Okahashi N; Kuwata H
    Biochem Biophys Res Commun; 2017 Apr; 485(2):461-467. PubMed ID: 28202416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.
    Schurek KN; Adam HJ; Siemens CG; Hoban CJ; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2005 Oct; 56(4):769-72. PubMed ID: 16126779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological and Chemical Adaptation to Endogenous Hydrogen Peroxide Production in
    Lisher JP; Tsui HT; Ramos-Montañez S; Hentchel KL; Martin JE; Trinidad JC; Winkler ME; Giedroc DP
    mSphere; 2017; 2(1):. PubMed ID: 28070562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular epidemiology of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae in Seville.
    Iraurgui P; Torres MJ; Aznar J
    Enferm Infecc Microbiol Clin; 2012 Apr; 30(4):180-3. PubMed ID: 22365183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights into the evolutionary trajectories of fluoroquinolone resistance in Streptococcus pneumoniae.
    Zhang G; Wang C; Sui Z; Feng J
    J Antimicrob Chemother; 2015 Sep; 70(9):2499-506. PubMed ID: 26031465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005.
    Ip M; Chau SS; Chi F; Cheuk ES; Ma H; Lai RW; Chan PK
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2192-4. PubMed ID: 17371818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyruvate Oxidase as a Key Determinant of Pneumococcal Viability during Transcytosis across Brain Endothelium.
    Anil A; Apte S; Joseph J; Parthasarathy A; Madhavan S; Banerjee A
    J Bacteriol; 2021 Nov; 203(24):e0043921. PubMed ID: 34606370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular determinants of the bacterial resistance to fluoroquinolones: a computational study.
    Lupala CS; Gomez-Gutierrez P; Perez JJ
    Curr Comput Aided Drug Des; 2013 Jun; 9(2):281-8. PubMed ID: 23106777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacin exposure in a rabbit tissue cage model.
    Xuan D; Zhong M; Mattoes H; Bui KQ; McNabb J; Nicolau DP; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 2001 Mar; 45(3):794-9. PubMed ID: 11181363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous H2O2 produced by Streptococcus pneumoniae controls FabF activity.
    Benisty R; Cohen AY; Feldman A; Cohen Z; Porat N
    Biochim Biophys Acta; 2010 Sep; 1801(9):1098-104. PubMed ID: 20601114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy.
    Montanari MP; Tili E; Cochetti I; Mingoia M; Manzin A; Varaldo PE
    Microb Drug Resist; 2004; 10(3):209-17. PubMed ID: 15383164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae.
    Sierra JM; Cabeza JG; Ruiz Chaler M; Montero T; Hernandez J; Mensa J; Llagostera M; Vila J
    Clin Microbiol Infect; 2005 Sep; 11(9):750-8. PubMed ID: 16104991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae.
    El Garch F; Lismond A; Piddock LJ; Courvalin P; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2010 Oct; 65(10):2076-82. PubMed ID: 20709735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct Regulatory Role of Carbon Catabolite Protein A (CcpA) in Oral Streptococcal
    Redanz S; Masilamani R; Cullin N; Giacaman RA; Merritt J; Kreth J
    J Bacteriol; 2018 Apr; 200(8):. PubMed ID: 29378884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test.
    Ramakrishnan R; Ramesh S; Bharathi MJ; Amuthan M; Viswanathan S
    Indian J Pathol Microbiol; 2010; 53(2):276-80. PubMed ID: 20551532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.